- cafead Feb 12, 2024 at 11:52: AM
via Startups looking to go public now need advanced drug prospects and a management team with a “track record of success,” Maag told BioPharma Dive.
article source
article source
-
Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page
Kyverna CEO Peter Maag on courting investors in a ‘volatile’ IPO market
- Thread starter cafead
- Start date
<
Similar threads